| Name | Title | Contact Details |
|---|
Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopars pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma; MNPR101, a late-stage preclinical antibody for radiopharmaceutical use in advanced cancers; and MNPR202, an early-stage camsirubicin analog for various cancers.
Montgomery, Gray, is a Princeton, NJ-based company in the Business Services sector.
NP MICROSYSTEMS INC is a Edison, NJ-based company in the Business Services sector.
Toxics Targeting Inc is a Ithaca, NY-based company in the Business Services sector.
LEDIC Management Group is a Memphis, TN-based company in the Business Services sector.